INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

19,215 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
22
PA
Pisetsky Michael A.SVP, Ops & Adm/Chief Legal Ofr
SIBNSI-BONE, Inc.
Open-market sale
SELL$24K
1,300 sh
Oct 2, 2026Oct 6, 2026
Page 90 of 481
← PrevNext →
traded Oct 2, 2026
+4d
SEC Form 4

Evidence

21
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$181K
1,000 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

21
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$95K
500 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

19
LC
Lathan CorinnaDirector
PTCPTC INC.
Open-market sale · 10b5-1 plan
SELL$343K
1,750 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$816K
3,005 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$395K
1,455 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$515K
1,920 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$354K
1,308 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

17
DM
Daniels Ryan M.SVP, Wood Products
RYNRAYONIER INC
Open-market sale
SELL$255
14 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$207K
760 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$108K
400 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$86K
317 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$195K
720 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC Form 4

Evidence

15
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$7.00M
72.0K sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC Form 4

Evidence

15
PM
Pauls MatthewDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$17K
786 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

14
CC
Chen Sean ChihhsiangPresident and COO
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$366K
5,508 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC Form 4

Evidence

13
PS
Perry Jennifer ScottChief Operating Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale · 10b5-1 plan
SELL$3,796
1,094 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

13
PS
Perry Jennifer ScottChief Operating Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale · 10b5-1 plan
SELL$285
80 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC Form 4

Evidence

13
PS
Perry Jennifer ScottChief Operating Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale · 10b5-1 plan
SELL$1,232
326 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC Form 4

Evidence

13
MR
Moll Laurent RChief Operating Officer
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$297K
12.2K sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$11K
40 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC Form 4

Evidence

12
NS
Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY
MGTXMeiraGTx Holdings plc
Open-market sale · 10b5-1 plan
SELL$294K
27.7K sh
Oct 6, 2026Oct 6, 2026
traded Oct 6, 2026
+0dSEC Form 4

Evidence

11
CC
Chen Sean ChihhsiangPresident and COO
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$172K
2,492 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

11
GP
Greenleaf PeterDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$17K
797 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

11
CC
Chen Sean ChihhsiangPresident and COO
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$54K
800 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC Form 4

Evidence

11
CC
Chen Sean ChihhsiangPresident and COO
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$210K
3,008 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

11
CC
Chen Sean ChihhsiangPresident and COO
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$121K
1,797 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC Form 4

Evidence

11
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$2.03M
21.0K sh
Oct 6, 2026Oct 6, 2026
traded Oct 6, 2026
+0dSEC Form 4

Evidence

11
FM
Friedberg Ezra MDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$12K
558 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

10
AL
Alpern Paul LVP and General Counsel
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$146K
6,003 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC Form 4

Evidence

8
BG
Bowles GregoryChief Policy Officer
JOBYJoby Aviation, Inc.
Open-market sale · 10b5-1 plan
SELL$31K
5,302 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC Form 4

Evidence

8
CC
Chen Sean ChihhsiangPresident and COO
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$22K
302 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

8
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$600K
1,976 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

8
CC
Chen Sean ChihhsiangPresident and COO
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$6,951
100 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC Form 4

Evidence

7
AF
Assaderaghi FariborzSee Remarks
SITMSITIME Corp
Open-market sale · 10b5-1 plan
SELL$963K
1,374 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

4
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$252K
833 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

4
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$467K
1,535 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

3
MA
Maheshwari AnshulChief Op & Financial Officer
SIBNSI-BONE, Inc.
Open-market sale · 10b5-1 plan
SELL$28K
1,560 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

3
MR
Moll Laurent RChief Operating Officer
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$47K
1,889 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

3
MA
Maheshwari AnshulChief Op & Financial Officer
SIBNSI-BONE, Inc.
Open-market sale · 10b5-1 plan
SELL$32K
1,758 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence